109 related articles for article (PubMed ID: 30945332)
1. Molecular alterations of mitochondrial D-loop in oral leukoplakia.
Elamir A; ElRefai SM; Ghazy SE
J Cell Biochem; 2019 Aug; 120(8):13944-13951. PubMed ID: 30945332
[TBL] [Abstract][Full Text] [Related]
2. D-loop somatic mutations and ∼5 kb "common" deletion in mitochondrial DNA: important molecular markers to distinguish oral precancer and cancer.
Datta S; Chattopadhyay E; Ray JG; Majumder M; Roy PD; Roy B
Tumour Biol; 2015 Apr; 36(4):3025-33. PubMed ID: 25527154
[TBL] [Abstract][Full Text] [Related]
3. Association of DNA sequence variation in mitochondrial DNA polymerase with mitochondrial DNA synthesis and risk of oral cancer.
Datta S; Ray A; Roy R; Roy B
Gene; 2016 Jan; 575(2 Pt 3):650-4. PubMed ID: 26403317
[TBL] [Abstract][Full Text] [Related]
4. Mutated and wild-type p53 expression and HPV integration in proliferative verrucous leukoplakia and oral squamous cell carcinoma.
Gopalakrishnan R; Weghorst CM; Lehman TA; Calvert RJ; Bijur G; Sabourin CL; Mallery SR; Schuller DE; Stoner GD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Apr; 83(4):471-7. PubMed ID: 9127380
[TBL] [Abstract][Full Text] [Related]
5. Frequent alterations of p16INK4a and p14ARF in oral proliferative verrucous leukoplakia.
Kresty LA; Mallery SR; Knobloch TJ; Li J; Lloyd M; Casto BC; Weghorst CM
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3179-87. PubMed ID: 18990760
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of expression of p53 tumor suppressor gene in human oral squamous cell carcinoma].
Okuno-Ishii N
Kokubyo Gakkai Zasshi; 1993 Mar; 60(1):131-48. PubMed ID: 8482898
[TBL] [Abstract][Full Text] [Related]
7. Gallbladder carcinoma: high rate of mitochondrial D-loop mutations.
Maurya SK; Tewari M; Shukla HS
Diagn Mol Pathol; 2013 Jun; 22(2):119-22. PubMed ID: 23628824
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions.
Kim MM; Clinger JD; Masayesva BG; Ha PK; Zahurak ML; Westra WH; Califano JA
Clin Cancer Res; 2004 Dec; 10(24):8512-5. PubMed ID: 15623632
[TBL] [Abstract][Full Text] [Related]
10. [Significance of the mitochondrial D-loop alterations in hyperplastic pancreatic ductal cells in the vicinity of pancreatic cancer coexisting with chronic pancreatitis].
Mu DQ; Gao LJ; Peng SY; Li JT
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):433-7. PubMed ID: 17152489
[TBL] [Abstract][Full Text] [Related]
11. GSTM1 null polymorphism prevalence in tobacco users, oral leukoplakia and oral squamous cell carcinoma patients in South Indian population: A polymerase chain reaction study.
Tanwar R; Iyengar AR; Nagesh KS; Patil S; Subhash BV
Indian J Dent Res; 2016; 27(4):353-358. PubMed ID: 27723629
[TBL] [Abstract][Full Text] [Related]
12. Short telomeres in an oral precancerous lesion: Q-FISH analysis of leukoplakia.
Aida J; Kobayashi T; Saku T; Yamaguchi M; Shimomura N; Nakamura K; Ishikawa N; Maruyama S; Cheng J; Poon SS; Sawabe M; Arai T; Takubo K
J Oral Pathol Med; 2012 May; 41(5):372-8. PubMed ID: 22122732
[TBL] [Abstract][Full Text] [Related]
13. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal study of TP53 mutations in eight patients with potentially malignant oral mucosal disorders.
Ogmundsdóttir HM; Hilmarsdóttir H; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Oct; 38(9):716-21. PubMed ID: 19473449
[TBL] [Abstract][Full Text] [Related]
15. A qualitative and quantitative estimation of AgNORS in dysplastic and non-dysplastic leukoplakias.
Pandit S; Aithal D
Indian J Dent Res; 2002; 13(1):27-30. PubMed ID: 12420565
[TBL] [Abstract][Full Text] [Related]
16. Sequence and expression variations in 23 genes involved in mitochondrial and non-mitochondrial apoptotic pathways and risk of oral leukoplakia and cancer.
Datta S; Ray A; Singh R; Mondal P; Basu A; De Sarkar N; Majumder M; Maiti G; Baral A; Jha GN; Mukhopadhyay I; Panda C; Chowdhury S; Ghosh S; Roychoudhury S; Roy B
Mitochondrion; 2015 Nov; 25():28-33. PubMed ID: 26403071
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiles of oral leukoplakia and carcinoma: genome-wide comparison analysis using oligonucleotide microarray technology.
Odani T; Ito D; Li MH; Kawamata A; Isobe T; Iwase M; Nagumo M
Int J Oncol; 2006 Mar; 28(3):619-24. PubMed ID: 16465365
[TBL] [Abstract][Full Text] [Related]
18. Salivary mRNA markers having the potential to detect oral squamous cell carcinoma segregated from oral leukoplakia with dysplasia.
Michailidou E; Tzimagiorgis G; Chatzopoulou F; Vahtsevanos K; Antoniadis K; Kouidou S; Markopoulos A; Antoniades D
Cancer Epidemiol; 2016 Aug; 43():112-8. PubMed ID: 27263493
[TBL] [Abstract][Full Text] [Related]
19. [Expressions of PDCD5 and p53 in oral leukoplakia and oral squamous cell carcinoma].
Zhao XY; Liu HW; Wei MJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):429-32. PubMed ID: 16086069
[TBL] [Abstract][Full Text] [Related]
20. AgNOR count as objective marker for dysplastic features in oral leukoplakia.
Chattopadhyay A; Ray JG; Caplan DJ
J Oral Pathol Med; 2002 Oct; 31(9):512-7. PubMed ID: 12269989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
